Source: Investing.com ↗

Laidlaw initiates Aeon Biopharma stock coverage with buy rating

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,928.65

+0.24%

ETH/USDT

$2,736.32

+0.14%

ZEC/USDT

$1,611.99

+7.88%

XRP/USDT

$1.60

+4.10%